These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29846725)

  • 21. Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
    Ackermann EJ; Guo S; Benson MD; Booten S; Freier S; Hughes SG; Kim TW; Jesse Kwoh T; Matson J; Norris D; Yu R; Watt A; Monia BP
    Amyloid; 2016 Sep; 23(3):148-157. PubMed ID: 27355239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of alternative complement pathway dysregulation by a phosphorothioate oligonucleotide in monkey and human serum.
    Henry SP; Jagels MA; Hugli TE; Manalili S; Geary RS; Giclas PC; Levin AA
    Nucleic Acid Ther; 2014 Oct; 24(5):326-35. PubMed ID: 25093529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
    Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicological properties of several novel oligonucleotide analogs in mice.
    Henry SP; Zuckerman JE; Rojko J; Hall WC; Harman RJ; Kitchen D; Crooke ST
    Anticancer Drug Des; 1997 Jan; 12(1):1-14. PubMed ID: 9051110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice.
    Yu RZ; Zhang H; Geary RS; Graham M; Masarjian L; Lemonidis K; Crooke R; Dean NM; Levin AA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):388-95. PubMed ID: 11160622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal distribution and metabolism of 2'-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
    Butler M; Hayes CS; Chappell A; Murray SF; Yaksh TL; Hua XY
    Neuroscience; 2005; 131(3):705-15. PubMed ID: 15730875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys.
    Monteith DK; Geary RS; Leeds JM; Johnston J; Monia BP; Levin AA
    Toxicol Sci; 1998 Dec; 46(2):365-75. PubMed ID: 10048140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro metabolic stabilities and metabolism of 2'-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenates.
    Baek MS; Yu RZ; Gaus H; Grundy JS; Geary RS
    Oligonucleotides; 2010 Dec; 20(6):309-16. PubMed ID: 21117960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes.
    Yu RZ; Geary RS; Leeds JM; Watanabe T; Fitchett JR; Matson JE; Mehta R; Hardee GR; Templin MV; Huang K; Newman MS; Quinn Y; Uster P; Zhu G; Working PK; Horner M; Nelson J; Levin AA
    Pharm Res; 1999 Aug; 16(8):1309-15. PubMed ID: 10468036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet sequestration with a new-generation autotransfusion device.
    Seyfried TF; Streithoff F; Gruber M; Unterbuchner C; Zech N; Kieninger M; Hansen E
    Transfusion; 2018 Apr; 58(4):989-997. PubMed ID: 29380387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of platelet-derived extracellular vesicles in plateletpheresis concentrates: a multicenter study.
    Black A; Orsó E; Kelsch R; Pereira M; Kamhieh-Milz J; Salama A; Fischer MB; Meyer E; Frey BM; Schmitz G
    Transfusion; 2017 Jun; 57(6):1459-1469. PubMed ID: 28394090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and Disposition of Volanesorsen, a 2'-
    Post N; Yu R; Greenlee S; Gaus H; Hurh E; Matson J; Wang Y
    Drug Metab Dispos; 2019 Oct; 47(10):1164-1173. PubMed ID: 31350288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single and repeated intravenous toxicity studies of pamiteplase (genetical recombination) in rats and monkeys.
    Ishikawa A; Ohata T; Imamura K; Iwasaki M; Sakai T; Matsuzawa T; Okazaki S
    J Toxicol Sci; 1997 May; 22(2):117-33. PubMed ID: 9198009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C.
    Homoncik M; Ferlitsch A; Ferenci P; Formann E; Jilma B; Gangl A; Panzer S; Peck-Radosavljevic M
    Aliment Pharmacol Ther; 2005 Jan; 21(1):49-55. PubMed ID: 15644045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of toxaphene on the immune system of cynomolgus (Macaca fascicularis) monkeys.
    Tryphonas H; Arnold DL; Bryce F; Huang J; Hodgen M; Ladouceur DT; Fernie S; Lepage-Parenteau M; Hayward S
    Food Chem Toxicol; 2001 Sep; 39(9):947-58. PubMed ID: 11498272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived extracellular vesicles in plateletpheresis concentrates as a quality control approach.
    Black A; Pienimaeki-Roemer A; Kenyon O; Orsó E; Schmitz G
    Transfusion; 2015 Sep; 55(9):2184-96. PubMed ID: 26032769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.